Primary research consultants at FMI’s healthcare domain project that the global surface plasmon resonance system market is poised to reach a valuation of USD 1.0 billion by 2024.
The positive trend will endure, with forecasts indicating that the market will escalate to USD 1.6 billion by 2034. This equates to a moderate CAGR of 5.1% over the forecast period.
| Attributes | Key Insights |
|---|---|
| Surface Plasmon Resonance System Market Estimated Size in 2024 | USD 1.0 billion |
| Projected Market Value in 2034 | USD 1.6 billion |
| Value-based CAGR from 2024 to 2034 | 5.1% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market for surface plasmon resonance system advanced at a 5.9% CAGR between 2019 and 2023. The market is slated to rise at a moderate CAGR of 5.1% over the forecast period 2024 to 2034. The market witnessed significant growth during the historical period, attributed to the increasing adoption of biopharmaceutical development.
The growing focus on biologics and biosimilars development boosted the demand for the systems for protein characterization, antibody screening, and quality control in biopharmaceutical manufacturing processes.
The surface plasmon resonance systems found new applications in areas such as environmental monitoring, food safety testing, and clinical diagnostics, driving market diversification and expansion.
The market also experienced consolidation through mergers, acquisitions, and partnerships among key players, which led to increased competition and innovation in the technology and instrumentation.
Looking forward to the forecast period, emerging economies will augment the market prospects. Integration of the systems with big data analytics platforms and artificial intelligence algorithms will enable advanced data analysis, pattern recognition, and predictive modeling,
The trend will enhance the efficiency and accuracy of molecular interaction studies and accelerating drug discovery processes. There will be a growing emphasis on developing miniaturized, portable systems for point of care diagnostics and personalized medicine applications. The factor will cater to the demand for rapid, decentralized testing and tailored therapeutic approaches.
Principal Consultant
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Country | The United States |
|---|---|
| CAGR through 2034 | 5.5% |
The surface plasmon resonance system market in the United States will expand at a CAGR of 5.5% through 2034. The country has a well established healthcare infrastructure, such as hospitals, clinical laboratories, and research facilities.
They provide a conducive environment for the adoption of SPR technology in clinical diagnostics, drug development, as well as biomedical research. The United States is home to a significant number of pharmaceutical, biotechnology, and academic research institutions engaged in drug discovery, biomolecular research, and biopharmaceutical development.
The robust research and development ecosystem fuels the demand for advanced analytical tools such as systems for studying biomolecular interactions.
| Country | The United Kingdom |
|---|---|
| CAGR through 2034 | 4.3% |
The surface plasmon resonance system market in the United Kingdom to expand at a CAGR of 4.3% through 2034. There is a growing demand for technologies that support drug discovery and development processes, with a robust pharmaceutical industry.
The systems play a vital role in drug screening, lead optimization, and characterization of drug target interactions, contributing to their adoption in pharmaceutical research and development in the country.
The United Kingdom is home to renowned universities, research institutions, and biomedical research centers conducting cutting edge research in areas such as drug discovery, molecular biology, and biophysics. The demand for advanced analytical tools like systems is driven by the need to study biomolecular interactions and accelerate scientific discoveries.
| Country | China |
|---|---|
| CAGR through 2034 | 6.5% |
Surface plasmon resonance system trends in China are taking a turn for the better. A 6.5% CAGR is forecast for the country from 2024 to 2034. China has a growing network of academic research institutions, universities, and research centers engaged in biomedical research, drug discovery, and molecular biology studies.
The demand for advanced analytical tools for studying biomolecular interactions and drug target interactions fuels the adoption of SPR technology in academic research laboratories.
The country is investing in precision medicine initiatives aimed at tailoring medical treatment and healthcare interventions to individual patient characteristics. Surface plasmon resonance systems support precision medicine efforts by enabling the study of personalized biomarkers, therapeutic targets, and drug response profiles, driving market growth in the healthcare sector.
| Country | India |
|---|---|
| CAGR through 2034 | 6.1% |
The surface plasmon resonance system market in India is poised to expand at a CAGR of 6.1% through 2034. High throughput screening technologies are in high demand in India for drug discovery, compound screening, and functional genomics studies.
The systems with high throughput capabilities enable rapid screening of compound libraries, lead identification, and optimization, meeting the needs of pharmaceutical and biotechnology industries.
Biotechnology hubs and innovation clusters are emerging in major Indian cities including Bengaluru, Hyderabad, and Pune, fostering collaboration, technology transfer, and commercialization of biotech products. The concentration of biotechnology companies, research institutes, and academic centers creates opportunities for the adoption of systems in drug discovery, diagnostics, and biomanufacturing.
| Country | Australia and New Zealand |
|---|---|
| CAGR through 2034 | 5.1% |
The surface plasmon resonance system market in Australia and New Zealand will expand at a CAGR of 5.1% through 2034. Collaboration between Australian and New Zealand research institutions, biotechnology companies, and international partners fosters technology exchange, knowledge transfer, and market access for systems.
Strategic partnerships with foreign manufacturers and distributors contribute to market expansion and technology adoption. Australia and New Zealand have well established healthcare systems with a growing emphasis on diagnostics as well as personalized medicine.
The systems are increasingly used in clinical diagnostics for biomarker analysis, infectious disease detection, and therapeutic monitoring, contributing to market growth in the healthcare sector.
The below table highlights how imaging system segment is leading the market in terms of product type, and will account for a CAGR of 56.8% through 2034.
Based on application, the drug discovery segment is gaining heights and will to account for a CAGR of 67.4% through 2034.
| Category | CAGR through 2034 |
|---|---|
| Imaging System | 56.8% |
| Drug Discovery | 67.4% |
Based on product type, the imaging system segment will dominate the surface plasmon resonance system market. Imaging systems integrated with the surface plasmon resonance technology offer real time visualization and monitoring of biomolecular interactions at the sensor surface.
The capability provides researchers with valuable insights into binding kinetics, affinity measurements, and molecular dynamics, boosting the demand for imaging enabled systems.
Imaging systems enhance the sensitivity and detection capability of the surface plasmon resonance platforms by enabling the simultaneous detection of multiple analytes or interaction events across the sensor surface. The multiplexing capability expands the analytical utility of the systems in complex biological samples and high throughput screening applications.
By application, the drug discovery segment will dominate the surface plasmon resonance system market. The surface plasmon resonance technology accelerates the hit identification and lead optimization phases of drug discovery by enabling rapid screening of compound libraries against target proteins or biomolecules.
The high sensitivity and throughput of SPR systems facilitate the identification of lead compounds with favorable binding kinetics, potency, and selectivity. Drug discovery requires efficient and reliable methods for identifying potential drug candidates from large compound libraries.
The systems offer label free, real time analysis of biomolecular interactions, making them valuable tools for screening small molecule compounds, peptides, and biologics in early stage drug discovery.
The surface plasmon resonance system market is characterized by the presence of several established players and emerging companies offering a diverse range of instrumentation, consumables, as well as services.
Company Portfolio
| Attribute | Details |
|---|---|
| Estimated Market Size in 2024 | USD 1.0 billion |
| Projected Market Valuation in 2034 | USD 1.6 billion |
| Value-based CAGR 2024 to 2034 | 5.1% |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | Value in USD Billion |
| Key Regions Covered | North America; Latin America; Western Europe; Eastern Europe; South Asia and Pacific; East Asia; The Middle East & Africa |
| Key Market Segments Covered | Product, Application, End User, Region |
| Key Countries Profiled | The United States, Canada, Brazil, Mexico, Germany, France, France, Spain, Italy, Russia, Poland, Czech Republic, Romania, India, Bangladesh, Australia, New Zealand, China, Japan, South Korea, GCC countries, South Africa, Israel |
| Key Companies Profiled | Biacore (acquired by GE Healthcare); Bio-Rad Laboratories; Attana AB; Nicoya; BioNavis Ltd.; Reichert Technologies; Biosensing Instrument Inc.; GWC Technologies Inc.; Plexera Bioscience LLC; Horiba Scientific; Sensata Technologies; Carterra Inc.; AMETEK Advanced Motion Solutions; Genoptix (a Novartis company); BiOptix Diagnostics (acquired by ForteBio); Insplorion AB; SPR Therapeutics; Ssens BV; Kinetic Biosystems; Sierra Sensors GmbH |
The surface plasmon resonance system market is projected to reach a valuation of USD 1.0 billion in 2024.
The surface plasmon resonance system industry is set to expand by a CAGR of 5.1% through 2034.
The surface plasmon resonance system market is forecast to reach USD 1.6 billion by 2034.
China is set to be the top performing market, exhibiting a CAGR of 6.5% through 2034.
Imaging system segment is preferred, and will account for a share of 56.8% in 2024.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product 5.1. Imaging System 5.2. Sensor System 5.3. Reagents 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application 6.1. Drug Discovery 6.2. Material Science 6.3. Biosensors 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User 7.1. Academic & Research Institutes 7.2. Food & Beverage Industry 7.3. Biopharmaceutical Companies 7.4. Contract Research Organization (CRO) 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 8.1. North America 8.2. Latin America 8.3. Western Europe 8.4. Eastern Europe 8.5. South Asia and Pacific 8.6. East Asia 8.7. Middle East and Africa 9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 16. Key Countries Market Analysis 17. Market Structure Analysis 18. Competition Analysis 18.1. Bio-Rad Laboratories 18.2. Attana AB 18.3. Nicoya 18.4. BioNavis Ltd. 18.5. Reichert Technologies 18.6. Biosensing Instrument Inc. 18.7. GWC Technologies Inc. 18.8. Plexera Bioscience LLC 18.9. Horiba Scientific 18.10. Sensata Technologies 18.11. Carterra, Inc. 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Surface Plasmon Resonance System Market
